JPRN-jRCT2080220769未知3 期
Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis
DAIICHISANKYO Co.,Ltd.0 个研究点开始时间: 2009年7月16日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Involutional (postmenopausal and senile) osteoporotic subjects with prevalent fragility vertebral fracture(s)
排除标准
- 未提供
研究者
相似试验
尚未招募
1 期
A Randomized placebo clinical study and life style interventionon Mesha Shringyadi Gugglu in MedovridhhiCTRI/2016/03/006709IPGT and RA Gau Jamnagar40
尚未招募
不适用
To understand efficacy of Calcarea Phospharica 6x in improving health status of children with Malnutrition in age group of 1-5 years.CTRI/2021/08/035387ipoid Foundation
已完成
不适用
A randomised controlled placebo based trial to determine the efficacy of a prophylactic dose of hydrocortisone and anti histamine in preventing reactions to anti snake venom (ASV)Anaphylactoid and pryogenic reactions to anti snake venomInjury, Occupational Diseases, PoisoningReactions to anti snake venomISRCTN29425449St John's Medical College (India)250
进行中（未招募）
1 期
A placebo-controlled, multiple dose, phase IIb, dose guiding trial to explore safety and tolerability of four weeks treatment with sulthiame in patients with moderate to severe obstructive sleep apneaModerate to severe obstructive sleep apneaMedDRA version: 20.0Level: LLTClassification code 10055577Term: Obstructive sleep apnea syndromeSystem Organ Class: 100000004855EUCTR2017-004767-13-SEDesitin Arzneimittel GmbH68
已完成
1 期
Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of ALD403Neurological - Other neurological disordersMigraineACTRN12615000531516Alder BioPharmaceuticals, Inc.60